Global In Vitro Diagnostic (IVD) Reagents Market Research Report 2021

Publisher Name :
Date: 25-Feb-2021
No. of pages: 123
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Immune Diagnosis

- Clinical and Biochemical

- Molecular Diagnosis

- POCT

- Other

Segment by Application

- Hospital

- Laboratory

- Other

- In 2018, hospitals account for about 48.54% of the total downstream market. It is predicted that the market share of downstream hospitals will remain stable from 2019 to 2025.

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Roche

- Danaher

- Abbott Laboratories

- Thermal Fisher

- Sysmex Corporation

- Biomerieux

- Siemens

- Ortho Clinical Diagnostics

- BD

- Bio-Rad

- Myriad Genetics

- Hologic

- QIAGEN

- Mindray Medical

- Wondfo

- KHB

- Da An Gene

- Leadman

- Biosino

Global In Vitro Diagnostic (IVD) Reagents Market Research Report 2021

Table of Contents
1 In Vitro Diagnostic (IVD) Reagents Market Overview
1.1 Product Overview and Scope of In Vitro Diagnostic (IVD) Reagents
1.2 In Vitro Diagnostic (IVD) Reagents Segment by Type
1.2.1 Global In Vitro Diagnostic (IVD) Reagents Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Immune Diagnosis
1.2.3 Clinical and Biochemical
1.2.4 Molecular Diagnosis
1.2.5 POCT
1.2.6 Other
1.3 In Vitro Diagnostic (IVD) Reagents Segment by Application
1.3.1 In Vitro Diagnostic (IVD) Reagents Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Other
1.4 Global In Vitro Diagnostic (IVD) Reagents Market Size Estimates and Forecasts
1.4.1 Global In Vitro Diagnostic (IVD) Reagents Revenue 2016-2027
1.4.2 Global In Vitro Diagnostic (IVD) Reagents Sales 2016-2027
1.4.3 In Vitro Diagnostic (IVD) Reagents Market Size by Region: 2016 Versus 2021 Versus 2027
2 In Vitro Diagnostic (IVD) Reagents Market Competition by Manufacturers
2.1 Global In Vitro Diagnostic (IVD) Reagents Sales Market Share by Manufacturers (2016-2021)
2.2 Global In Vitro Diagnostic (IVD) Reagents Revenue Market Share by Manufacturers (2016-2021)
2.3 Global In Vitro Diagnostic (IVD) Reagents Average Price by Manufacturers (2016-2021)
2.4 Manufacturers In Vitro Diagnostic (IVD) Reagents Manufacturing Sites, Area Served, Product Type
2.5 In Vitro Diagnostic (IVD) Reagents Market Competitive Situation and Trends
2.5.1 In Vitro Diagnostic (IVD) Reagents Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest In Vitro Diagnostic (IVD) Reagents Players Market Share by Revenue
2.5.3 Global In Vitro Diagnostic (IVD) Reagents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 In Vitro Diagnostic (IVD) Reagents Retrospective Market Scenario by Region
3.1 Global In Vitro Diagnostic (IVD) Reagents Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global In Vitro Diagnostic (IVD) Reagents Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America In Vitro Diagnostic (IVD) Reagents Market Facts & Figures by Country
3.3.1 North America In Vitro Diagnostic (IVD) Reagents Sales by Country
3.3.2 North America In Vitro Diagnostic (IVD) Reagents Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe In Vitro Diagnostic (IVD) Reagents Market Facts & Figures by Country
3.4.1 Europe In Vitro Diagnostic (IVD) Reagents Sales by Country
3.4.2 Europe In Vitro Diagnostic (IVD) Reagents Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Facts & Figures by Region
3.5.1 Asia Pacific In Vitro Diagnostic (IVD) Reagents Sales by Region
3.5.2 Asia Pacific In Vitro Diagnostic (IVD) Reagents Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America In Vitro Diagnostic (IVD) Reagents Market Facts & Figures by Country
3.6.1 Latin America In Vitro Diagnostic (IVD) Reagents Sales by Country
3.6.2 Latin America In Vitro Diagnostic (IVD) Reagents Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa In Vitro Diagnostic (IVD) Reagents Market Facts & Figures by Country
3.7.1 Middle East and Africa In Vitro Diagnostic (IVD) Reagents Sales by Country
3.7.2 Middle East and Africa In Vitro Diagnostic (IVD) Reagents Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global In Vitro Diagnostic (IVD) Reagents Historic Market Analysis by Type
4.1 Global In Vitro Diagnostic (IVD) Reagents Sales Market Share by Type (2016-2021)
4.2 Global In Vitro Diagnostic (IVD) Reagents Revenue Market Share by Type (2016-2021)
4.3 Global In Vitro Diagnostic (IVD) Reagents Price by Type (2016-2021)
5 Global In Vitro Diagnostic (IVD) Reagents Historic Market Analysis by Application
5.1 Global In Vitro Diagnostic (IVD) Reagents Sales Market Share by Application (2016-2021)
5.2 Global In Vitro Diagnostic (IVD) Reagents Revenue Market Share by Application (2016-2021)
5.3 Global In Vitro Diagnostic (IVD) Reagents Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Roche Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Danaher
6.2.1 Danaher Corporation Information
6.2.2 Danaher Description and Business Overview
6.2.3 Danaher In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Danaher Product Portfolio
6.2.5 Danaher Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Corporation Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Abbott Laboratories Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Thermal Fisher
6.4.1 Thermal Fisher Corporation Information
6.4.2 Thermal Fisher Description and Business Overview
6.4.3 Thermal Fisher In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Thermal Fisher Product Portfolio
6.4.5 Thermal Fisher Recent Developments/Updates
6.5 Sysmex Corporation
6.5.1 Sysmex Corporation Corporation Information
6.5.2 Sysmex Corporation Description and Business Overview
6.5.3 Sysmex Corporation In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Sysmex Corporation Product Portfolio
6.5.5 Sysmex Corporation Recent Developments/Updates
6.6 Biomerieux
6.6.1 Biomerieux Corporation Information
6.6.2 Biomerieux Description and Business Overview
6.6.3 Biomerieux In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Biomerieux Product Portfolio
6.6.5 Biomerieux Recent Developments/Updates
6.7 Siemens
6.6.1 Siemens Corporation Information
6.6.2 Siemens Description and Business Overview
6.6.3 Siemens In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Siemens Product Portfolio
6.7.5 Siemens Recent Developments/Updates
6.8 Ortho Clinical Diagnostics
6.8.1 Ortho Clinical Diagnostics Corporation Information
6.8.2 Ortho Clinical Diagnostics Description and Business Overview
6.8.3 Ortho Clinical Diagnostics In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Ortho Clinical Diagnostics Product Portfolio
6.8.5 Ortho Clinical Diagnostics Recent Developments/Updates
6.9 BD
6.9.1 BD Corporation Information
6.9.2 BD Description and Business Overview
6.9.3 BD In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.9.4 BD Product Portfolio
6.9.5 BD Recent Developments/Updates
6.10 Bio-Rad
6.10.1 Bio-Rad Corporation Information
6.10.2 Bio-Rad Description and Business Overview
6.10.3 Bio-Rad In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Bio-Rad Product Portfolio
6.10.5 Bio-Rad Recent Developments/Updates
6.11 Myriad Genetics
6.11.1 Myriad Genetics Corporation Information
6.11.2 Myriad Genetics In Vitro Diagnostic (IVD) Reagents Description and Business Overview
6.11.3 Myriad Genetics In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Myriad Genetics Product Portfolio
6.11.5 Myriad Genetics Recent Developments/Updates
6.12 Hologic
6.12.1 Hologic Corporation Information
6.12.2 Hologic In Vitro Diagnostic (IVD) Reagents Description and Business Overview
6.12.3 Hologic In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Hologic Product Portfolio
6.12.5 Hologic Recent Developments/Updates
6.13 QIAGEN
6.13.1 QIAGEN Corporation Information
6.13.2 QIAGEN In Vitro Diagnostic (IVD) Reagents Description and Business Overview
6.13.3 QIAGEN In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.13.4 QIAGEN Product Portfolio
6.13.5 QIAGEN Recent Developments/Updates
6.14 Mindray Medical
6.14.1 Mindray Medical Corporation Information
6.14.2 Mindray Medical In Vitro Diagnostic (IVD) Reagents Description and Business Overview
6.14.3 Mindray Medical In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Mindray Medical Product Portfolio
6.14.5 Mindray Medical Recent Developments/Updates
6.15 Wondfo
6.15.1 Wondfo Corporation Information
6.15.2 Wondfo In Vitro Diagnostic (IVD) Reagents Description and Business Overview
6.15.3 Wondfo In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Wondfo Product Portfolio
6.15.5 Wondfo Recent Developments/Updates
6.16 KHB
6.16.1 KHB Corporation Information
6.16.2 KHB In Vitro Diagnostic (IVD) Reagents Description and Business Overview
6.16.3 KHB In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.16.4 KHB Product Portfolio
6.16.5 KHB Recent Developments/Updates
6.17 Da An Gene
6.17.1 Da An Gene Corporation Information
6.17.2 Da An Gene In Vitro Diagnostic (IVD) Reagents Description and Business Overview
6.17.3 Da An Gene In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Da An Gene Product Portfolio
6.17.5 Da An Gene Recent Developments/Updates
6.18 Leadman
6.18.1 Leadman Corporation Information
6.18.2 Leadman In Vitro Diagnostic (IVD) Reagents Description and Business Overview
6.18.3 Leadman In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Leadman Product Portfolio
6.18.5 Leadman Recent Developments/Updates
6.19 Biosino
6.19.1 Biosino Corporation Information
6.19.2 Biosino In Vitro Diagnostic (IVD) Reagents Description and Business Overview
6.19.3 Biosino In Vitro Diagnostic (IVD) Reagents Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Biosino Product Portfolio
6.19.5 Biosino Recent Developments/Updates
7 In Vitro Diagnostic (IVD) Reagents Manufacturing Cost Analysis
7.1 In Vitro Diagnostic (IVD) Reagents Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of In Vitro Diagnostic (IVD) Reagents
7.4 In Vitro Diagnostic (IVD) Reagents Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 In Vitro Diagnostic (IVD) Reagents Distributors List
8.3 In Vitro Diagnostic (IVD) Reagents Customers
9 In Vitro Diagnostic (IVD) Reagents Market Dynamics
9.1 In Vitro Diagnostic (IVD) Reagents Industry Trends
9.2 In Vitro Diagnostic (IVD) Reagents Growth Drivers
9.3 In Vitro Diagnostic (IVD) Reagents Market Challenges
9.4 In Vitro Diagnostic (IVD) Reagents Market Restraints
10 Global Market Forecast
10.1 In Vitro Diagnostic (IVD) Reagents Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of In Vitro Diagnostic (IVD) Reagents by Type (2022-2027)
10.1.2 Global Forecasted Revenue of In Vitro Diagnostic (IVD) Reagents by Type (2022-2027)
10.2 In Vitro Diagnostic (IVD) Reagents Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of In Vitro Diagnostic (IVD) Reagents by Application (2022-2027)
10.2.2 Global Forecasted Revenue of In Vitro Diagnostic (IVD) Reagents by Application (2022-2027)
10.3 In Vitro Diagnostic (IVD) Reagents Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of In Vitro Diagnostic (IVD) Reagents by Region (2022-2027)
10.3.2 Global Forecasted Revenue of In Vitro Diagnostic (IVD) Reagents by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global In Vitro Diagnostic (IVD) Reagents Sales (Million Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global In Vitro Diagnostic (IVD) Reagents Sales (Million Units) Comparison by Application (2021-2027)
Table 3. Global In Vitro Diagnostic (IVD) Reagents Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers In Vitro Diagnostic (IVD) Reagents Covered in This Study
Table 5. Global In Vitro Diagnostic (IVD) Reagents Sales (Million Units) of Key Manufacturers (2016-2021)
Table 6. Global In Vitro Diagnostic (IVD) Reagents Sales Share by Manufacturers (2016-2021)
Table 7. Global In Vitro Diagnostic (IVD) Reagents Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global In Vitro Diagnostic (IVD) Reagents Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market In Vitro Diagnostic (IVD) Reagents Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers In Vitro Diagnostic (IVD) Reagents Manufacturing Sites and Area Served
Table 11. Manufacturers In Vitro Diagnostic (IVD) Reagents Product Type
Table 12. Global In Vitro Diagnostic (IVD) Reagents Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global In Vitro Diagnostic (IVD) Reagents by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In Vitro Diagnostic (IVD) Reagents as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global In Vitro Diagnostic (IVD) Reagents Sales by Region (2016-2021) & (Million Units)
Table 16. Global In Vitro Diagnostic (IVD) Reagents Sales Market Share by Region (2016-2021)
Table 17. Global In Vitro Diagnostic (IVD) Reagents Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America In Vitro Diagnostic (IVD) Reagents Sales by Country (2016-2021) & (Million Units)
Table 19. North America In Vitro Diagnostic (IVD) Reagents Sales Market Share by Country (2016-2021)
Table 20. North America In Vitro Diagnostic (IVD) Reagents Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America In Vitro Diagnostic (IVD) Reagents Revenue Market Share by Country (2016-2021)
Table 22. Europe In Vitro Diagnostic (IVD) Reagents Sales by Country (2016-2021) & (Million Units)
Table 23. Europe In Vitro Diagnostic (IVD) Reagents Sales Market Share by Country (2016-2021)
Table 24. Europe In Vitro Diagnostic (IVD) Reagents Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe In Vitro Diagnostic (IVD) Reagents Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific In Vitro Diagnostic (IVD) Reagents Sales by Region (2016-2021) & (Million Units)
Table 27. Asia Pacific In Vitro Diagnostic (IVD) Reagents Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific In Vitro Diagnostic (IVD) Reagents Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific In Vitro Diagnostic (IVD) Reagents Revenue Market Share by Region (2016-2021)
Table 30. Latin America In Vitro Diagnostic (IVD) Reagents Sales by Country (2016-2021) & (Million Units)
Table 31. Latin America In Vitro Diagnostic (IVD) Reagents Sales Market Share by Country (2016-2021)
Table 32. Latin America In Vitro Diagnostic (IVD) Reagents Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America In Vitro Diagnostic (IVD) Reagents Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa In Vitro Diagnostic (IVD) Reagents Sales by Country (2016-2021) & (Million Units)
Table 35. Middle East and Africa In Vitro Diagnostic (IVD) Reagents Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa In Vitro Diagnostic (IVD) Reagents Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa In Vitro Diagnostic (IVD) Reagents Revenue Market Share by Country (2016-2021)
Table 38. Global In Vitro Diagnostic (IVD) Reagents Sales (Million Units) by Type (2016-2021)
Table 39. Global In Vitro Diagnostic (IVD) Reagents Sales Market Share by Type (2016-2021)
Table 40. Global In Vitro Diagnostic (IVD) Reagents Revenue (Million US$) by Type (2016-2021)
Table 41. Global In Vitro Diagnostic (IVD) Reagents Revenue Share by Type (2016-2021)
Table 42. Global In Vitro Diagnostic (IVD) Reagents Price (US$/Unit) by Type (2016-2021)
Table 43. Global In Vitro Diagnostic (IVD) Reagents Sales (Million Units) by Application (2016-2021)
Table 44. Global In Vitro Diagnostic (IVD) Reagents Sales Market Share by Application (2016-2021)
Table 45. Global In Vitro Diagnostic (IVD) Reagents Revenue (Million US$) by Application (2016-2021)
Table 46. Global In Vitro Diagnostic (IVD) Reagents Revenue Share by Application (2016-2021)
Table 47. Global In Vitro Diagnostic (IVD) Reagents Price (US$/Unit) by Application (2016-2021)
Table 48. Roche Corporation Information
Table 49. Roche Description and Business Overview
Table 50. Roche In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Roche In Vitro Diagnostic (IVD) Reagents Product
Table 52. Roche Recent Developments/Updates
Table 53. Danaher Corporation Information
Table 54. Danaher Description and Business Overview
Table 55. Danaher In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Danaher In Vitro Diagnostic (IVD) Reagents Product
Table 57. Danaher Recent Developments/Updates
Table 58. Abbott Laboratories Corporation Information
Table 59. Abbott Laboratories Description and Business Overview
Table 60. Abbott Laboratories In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Abbott Laboratories In Vitro Diagnostic (IVD) Reagents Product
Table 62. Abbott Laboratories Recent Developments/Updates
Table 63. Thermal Fisher Corporation Information
Table 64. Thermal Fisher Description and Business Overview
Table 65. Thermal Fisher In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Thermal Fisher In Vitro Diagnostic (IVD) Reagents Product
Table 67. Thermal Fisher Recent Developments/Updates
Table 68. Sysmex Corporation Corporation Information
Table 69. Sysmex Corporation Description and Business Overview
Table 70. Sysmex Corporation In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Sysmex Corporation In Vitro Diagnostic (IVD) Reagents Product
Table 72. Sysmex Corporation Recent Developments/Updates
Table 73. Biomerieux Corporation Information
Table 74. Biomerieux Description and Business Overview
Table 75. Biomerieux In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Biomerieux In Vitro Diagnostic (IVD) Reagents Product
Table 77. Biomerieux Recent Developments/Updates
Table 78. Siemens Corporation Information
Table 79. Siemens Description and Business Overview
Table 80. Siemens In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Siemens In Vitro Diagnostic (IVD) Reagents Product
Table 82. Siemens Recent Developments/Updates
Table 83. Ortho Clinical Diagnostics Corporation Information
Table 84. Ortho Clinical Diagnostics Description and Business Overview
Table 85. Ortho Clinical Diagnostics In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Ortho Clinical Diagnostics In Vitro Diagnostic (IVD) Reagents Product
Table 87. Ortho Clinical Diagnostics Recent Developments/Updates
Table 88. BD Corporation Information
Table 89. BD Description and Business Overview
Table 90. BD In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. BD In Vitro Diagnostic (IVD) Reagents Product
Table 92. BD Recent Developments/Updates
Table 93. Bio-Rad Corporation Information
Table 94. Bio-Rad Description and Business Overview
Table 95. Bio-Rad In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Bio-Rad In Vitro Diagnostic (IVD) Reagents Product
Table 97. Bio-Rad Recent Developments/Updates
Table 98. Myriad Genetics Corporation Information
Table 99. Myriad Genetics Description and Business Overview
Table 100. Myriad Genetics In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Myriad Genetics In Vitro Diagnostic (IVD) Reagents Product
Table 102. Myriad Genetics Recent Developments/Updates
Table 103. Hologic Corporation Information
Table 104. Hologic Description and Business Overview
Table 105. Hologic In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Hologic In Vitro Diagnostic (IVD) Reagents Product
Table 107. Hologic Recent Developments/Updates
Table 108. QIAGEN Corporation Information
Table 109. QIAGEN Description and Business Overview
Table 110. QIAGEN In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. QIAGEN In Vitro Diagnostic (IVD) Reagents Product
Table 112. QIAGEN Recent Developments/Updates
Table 113. Mindray Medical Corporation Information
Table 114. Mindray Medical Description and Business Overview
Table 115. Mindray Medical In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Mindray Medical In Vitro Diagnostic (IVD) Reagents Product
Table 117. Mindray Medical Recent Developments/Updates
Table 118. Wondfo Corporation Information
Table 119. Wondfo Description and Business Overview
Table 120. Wondfo In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Wondfo In Vitro Diagnostic (IVD) Reagents Product
Table 122. Wondfo Recent Developments/Updates
Table 123. KHB Corporation Information
Table 124. KHB Description and Business Overview
Table 125. KHB In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. KHB In Vitro Diagnostic (IVD) Reagents Product
Table 127. KHB Recent Developments/Updates
Table 128. Da An Gene Corporation Information
Table 129. Da An Gene Description and Business Overview
Table 130. Da An Gene In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Da An Gene In Vitro Diagnostic (IVD) Reagents Product
Table 132. Da An Gene Recent Developments/Updates
Table 133. Leadman Corporation Information
Table 134. Leadman Description and Business Overview
Table 135. Leadman In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Leadman In Vitro Diagnostic (IVD) Reagents Product
Table 137. Leadman Recent Developments/Updates
Table 138. Biosino Corporation Information
Table 139. Biosino Description and Business Overview
Table 140. Biosino In Vitro Diagnostic (IVD) Reagents Sales (Million Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Biosino In Vitro Diagnostic (IVD) Reagents Product
Table 142. Biosino Recent Developments/Updates
Table 143. Production Base and Market Concentration Rate of Raw Material
Table 144. Key Suppliers of Raw Materials
Table 145. In Vitro Diagnostic (IVD) Reagents Distributors List
Table 146. In Vitro Diagnostic (IVD) Reagents Customers List
Table 147. In Vitro Diagnostic (IVD) Reagents Market Trends
Table 148. In Vitro Diagnostic (IVD) Reagents Growth Drivers
Table 149. In Vitro Diagnostic (IVD) Reagents Market Restraints
Table 150. Global In Vitro Diagnostic (IVD) Reagents Sales Forecast by Type (2022-2027) & (Million Units)
Table 151. Global In Vitro Diagnostic (IVD) Reagents Sales Market Share Forecast by Type (2022-2027)
Table 152. Global In Vitro Diagnostic (IVD) Reagents Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 153. Global In Vitro Diagnostic (IVD) Reagents Revenue Market Share Forecast by Type (2022-2027)
Table 154. Global In Vitro Diagnostic (IVD) Reagents Sales Forecast by Application (2022-2027) & (Million Units)
Table 155. Global In Vitro Diagnostic (IVD) Reagents Sales Market Share Forecast by Application (2022-2027)
Table 156. Global In Vitro Diagnostic (IVD) Reagents Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 157. Global In Vitro Diagnostic (IVD) Reagents Revenue Market Share Forecast by Application (2022-2027)
Table 158. Global In Vitro Diagnostic (IVD) Reagents Sales Forecast by Region (2022-2027) & (Million Units)
Table 159. Global In Vitro Diagnostic (IVD) Reagents Sales Market Share Forecast by Region (2022-2027)
Table 160. Global In Vitro Diagnostic (IVD) Reagents Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 161. Global In Vitro Diagnostic (IVD) Reagents Revenue Market Share Forecast by Region (2022-2027)
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of In Vitro Diagnostic (IVD) Reagents
Figure 2. Global In Vitro Diagnostic (IVD) Reagents Market Share by Type in 2020 & 2027
Figure 3. Immune Diagnosis Product Picture
Figure 4. Clinical and Biochemical Product Picture
Figure 5. Molecular Diagnosis Product Picture
Figure 6. POCT Product Picture
Figure 7. Other Product Picture
Figure 8. Global In Vitro Diagnostic (IVD) Reagents Market Share by Application in 2020 & 2027
Figure 9. Hospital
Figure 10. Laboratory
Figure 11. Other
Figure 12. Global In Vitro Diagnostic (IVD) Reagents Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global In Vitro Diagnostic (IVD) Reagents Market Size 2016-2027 (US$ Million)
Figure 14. Global In Vitro Diagnostic (IVD) Reagents Sales 2016-2027 (Million Units)
Figure 15. Global In Vitro Diagnostic (IVD) Reagents Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. In Vitro Diagnostic (IVD) Reagents Sales Share by Manufacturers in 2020
Figure 17. Global In Vitro Diagnostic (IVD) Reagents Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest In Vitro Diagnostic (IVD) Reagents Players: Market Share by Revenue in 2020
Figure 19. In Vitro Diagnostic (IVD) Reagents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global In Vitro Diagnostic (IVD) Reagents Sales Market Share by Region (2016-2021)
Figure 21. Global In Vitro Diagnostic (IVD) Reagents Sales Market Share by Region in 2020
Figure 22. Global In Vitro Diagnostic (IVD) Reagents Revenue Market Share by Region (2016-2021)
Figure 23. Global In Vitro Diagnostic (IVD) Reagents Revenue Market Share by Region in 2020
Figure 24. U.S. In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. UAE In Vitro Diagnostic (IVD) Reagents Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of In Vitro Diagnostic (IVD) Reagents by Type (2016-2021)
Figure 49. Sales Market Share of In Vitro Diagnostic (IVD) Reagents by Application (2016-2021)
Figure 50. Sales Market Share of In Vitro Diagnostic (IVD) Reagents by Application in 2020
Figure 51. Revenue Share of In Vitro Diagnostic (IVD) Reagen
  • Research Report on China's Mecapegfilgrastim Market, 2021-2025
    Published: 26-Nov-2021        Price: US 2600 Onwards        Pages: 40
    According to the International Agency for Research on Cancer (IARC) of the World Health Organization (WHO), China reported about 4.57 million new cancer cases in 2020, around 3 million of which were dead. Cancer treatments include surgery, radiation therapy and chemotherapy. Radiation therapy is one of the treatments that involves the use of high-energy waves (such as X-rays) to kill cancer cells. Radiotherapy can be used alone or in combination with other treatments (systemic therapy, surgery, ......
  • Research Report on China's Anlotinib Hydrochloride Market, 2021-2025
    Published: 26-Nov-2021        Price: US 2600 Onwards        Pages: 40
    Anlotinib hydrochloride is a novel small molecule multi-target tyrosine kinase inhibitor that effectively inhibits kinases like VEGFR, PDGFR, FGFR, and c-Kit with anti-tumor angiogenesis and tumor growth inhibition effects. The drug is a new Category 1.1 antitumor drug developed by the Chinese pharmaceutical company Nanjing Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Its clinical trials are already underway for a variety of cancers, including non-small cell lung cancer, soft tissue sarcoma,......
  • Global and Japan Pets Anti-infective Drugs Market Size, Status and Forecast 2021-2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 105
    Global Pets Anti-infective Drugs Scope and Market Size Pets Anti-infective Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pets Anti-infective Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. S......
  • Global and Japan Fibroblast Growth Factor Receptor 2 Inhibitor Market Size, Status and Forecast 2021-2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 115
    Global Fibroblast Growth Factor Receptor 2 Inhibitor Scope and Market Size Fibroblast Growth Factor Receptor 2 Inhibitor market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fibroblast Growth Factor Receptor 2 Inhibitor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of rev......
  • Global and Japan FGF-2 Inhibitors Market Size, Status and Forecast 2021-2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 124
    Global FGF-2 Inhibitors Scope and Market Size FGF-2 Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global FGF-2 Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027. Segment by Type - ASP......
  • Global and China Anlotinib Drugs Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 122
    Anlotinib Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anlotinib Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Anlotinib Drugs market si......
  • Global and Japan Osimertinib Drugs Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 121
    Osimertinib Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Osimertinib Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Osimertinib Drugs mar......
  • Global and China Regofinil Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 122
    Regofinil market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Regofinil market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For China market, this report focuses on the Regofinil market size by players, by ......
  • Global and Japan Alectinib Drugs Market Insights, Forecast to 2027
    Published: 17-Nov-2021        Price: US 3900 Onwards        Pages: 123
    Alectinib Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Alectinib Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027. For Japan market, this report focuses on the Alectinib Drugs market si......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs